Your browser doesn't support javascript.
loading
Giant Cell Tumors of the Upper Extremity: Predictors of Recurrence.
Lans, Jonathan; Oflazoglu, Kamil; Lee, Hang; Harness, Neil G; Castelein, René M; Chen, Neal C; Lozano Calderón, Santiago A.
Afiliação
  • Lans J; Department of Orthopaedic Surgery, Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address: jlans@mgh.harvard.edu.
  • Oflazoglu K; Department of Orthopaedic Surgery, Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Lee H; MGH Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Harness NG; Orthopedics Department, Southern California Permanente Medical Group, Anaheim, CA.
  • Castelein RM; Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Chen NC; Department of Orthopaedic Surgery, Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Lozano Calderón SA; Department of Orthopaedic Surgery, Orthopaedic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
J Hand Surg Am ; 45(8): 738-745, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32616409
PURPOSE: Giant cell tumors (GCT) of the distal radius are thought to be more aggressive than in other locations. Therefore, the aim of this study was to investigate factors associated with recurrence of GCTs in the upper extremity. METHODS: We retrospectively identified 82 patients who underwent primary surgical treatment for an upper extremity GCT. Tumors were located in the radius (n = 47), humerus (n = 17), ulna (n = 9), and hand (n = 9). Treatment consisted of either wide resection or amputation or intralesional resection with or without adjuvants. A multivariable logistic regression was performed including tumor grade, type of surgery, and tumor location, from which the percentage of contribution to the model of each variable was calculated. RESULTS: The recurrence rate after intralesional resection was 48%; after wide resection or amputation, it was 12%. Two patients developed a pulmonary metastasis (2.4%). In multivariable analysis, intralesional resection was independently associated with recurrence. Intralesional resection had a 77% contribution to predict recurrence and the distal radius location had a 16% contribution in the predictive model. CONCLUSIONS: As expected, intralesional resection was the strongest independent predictor of recurrence after surgical treatment for GCT. The distal radius location contributed to the prediction of giant cell tumor recurrence to a lesser extent. TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic IV.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Tumor de Células Gigantes do Osso Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Tumor de Células Gigantes do Osso Idioma: En Ano de publicação: 2020 Tipo de documento: Article